BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19100850)

  • 41. Nociceptin receptor activation does not alter acquisition, expression, extinction and reinstatement of conditioned cocaine preference in mice.
    Sartor GC; Powell SK; Wiedner HJ; Wahlestedt C; Brothers SP
    Brain Res; 2016 Feb; 1632():34-41. PubMed ID: 26657743
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of the noncompetitive NMDA receptor antagonist MK-801 on classical eyeblink conditioning in mice.
    Takatsuki K; Kawahara S; Takehara K; Kishimoto Y; Kirino Y
    Neuropharmacology; 2001 Oct; 41(5):618-28. PubMed ID: 11587717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanical hyperalgesia in rats with diabetic polyneuropathy is selectively inhibited by local peripheral nociceptin/orphanin FQ receptor and µ-opioid receptor agonism.
    Schiene K; Tzschentke TM; Schröder W; Christoph T
    Eur J Pharmacol; 2015 May; 754():61-5. PubMed ID: 25697471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SR 16435 [1-(1-(bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a novel mixed nociceptin/orphanin FQ/mu-opioid receptor partial agonist: analgesic and rewarding properties in mice.
    Khroyan TV; Zaveri NT; Polgar WE; Orduna J; Olsen C; Jiang F; Toll L
    J Pharmacol Exp Ther; 2007 Feb; 320(2):934-43. PubMed ID: 17132815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission.
    Eriksson TM; Madjid N; Elvander-Tottie E; Stiedl O; Svenningsson P; Ogren SO
    Neuropharmacology; 2008 Jun; 54(7):1041-50. PubMed ID: 18394658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The anxiolytic-like profile of the nociceptin receptor agonist, endo-8-[bis(2-chlorophenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octane-3-carboxamide (SCH 655842): comparison of efficacy and side effects across rodent species.
    Lu SX; Higgins GA; Hodgson RA; Hyde LA; Del Vecchio RA; Guthrie DH; Kazdoba T; McCool MF; Morgan CA; Bercovici A; Ho GD; Tulshian D; Parker EM; Hunter JC; Varty GB
    Eur J Pharmacol; 2011 Jul; 661(1-3):63-71. PubMed ID: 21545797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD.
    Andero R; Brothers SP; Jovanovic T; Chen YT; Salah-Uddin H; Cameron M; Bannister TD; Almli L; Stevens JS; Bradley B; Binder EB; Wahlestedt C; Ressler KJ
    Sci Transl Med; 2013 Jun; 5(188):188ra73. PubMed ID: 23740899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Time-dependent involvement of the dorsal hippocampus in trace fear conditioning in mice.
    Misane I; Tovote P; Meyer M; Spiess J; Ogren SO; Stiedl O
    Hippocampus; 2005; 15(4):418-26. PubMed ID: 15669102
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test.
    Rizzi A; Ruzza C; Bianco S; Trapella C; Calo' G
    Peptides; 2017 Aug; 94():71-77. PubMed ID: 28697954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice.
    Ribeiro Do Couto B; Aguilar MA; Manzanedo C; Rodríguez-Arias M; Miñarro J
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1035-43. PubMed ID: 15380865
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acquisition and expression of sucrose conditioned flavor preferences following dopamine D1, opioid and NMDA receptor antagonism in C57BL/6 mice.
    Fazilov G; Shenouda M; Iskhakov B; Buras A; Bhattacharjee D; Dohnalova P; Iskhakova J; Bourie F; Bodnar RJ
    Nutr Neurosci; 2020 Sep; 23(9):672-678. PubMed ID: 30465483
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.
    Ko MC; Woods JH; Fantegrossi WE; Galuska CM; Wichmann J; Prinssen EP
    Neuropsychopharmacology; 2009 Aug; 34(9):2088-96. PubMed ID: 19279568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Critical role of NMDA but not opioid receptors in the acquisition of fat-conditioned flavor preferences in rats.
    Dela Cruz JA; Bae VS; Icaza-Cukali D; Sampson C; Bamshad D; Samra A; Singh S; Khalifa N; Touzani K; Sclafani A; Bodnar RJ
    Neurobiol Learn Mem; 2012 Nov; 98(4):341-7. PubMed ID: 23103774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The nociceptin system and hippocampal cognition in mice: a pharmacological and genetic analysis.
    Kuzmin A; Madjid N; Johansson B; Terenius L; Ogren SO
    Brain Res; 2009 Dec; 1305 Suppl():S7-19. PubMed ID: 19782658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. N-Methyl-D-aspartate receptor antagonism blocks contextual fear conditioning and differentially regulates early growth response-1 messenger RNA expression in the amygdala: implications for a functional amygdaloid circuit of fear.
    Malkani S; Rosen JB
    Neuroscience; 2001; 102(4):853-61. PubMed ID: 11182248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cross state-dependency of learning between tramadol and MK-801 in the mouse dorsal hippocampus: involvement of nitric oxide (NO) signaling pathway.
    Jafari-Sabet M; Amiri S; Ataee R
    Psychopharmacology (Berl); 2018 Jul; 235(7):1987-1999. PubMed ID: 29679289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A NMDA receptor antagonist, MK-801 impairs consolidating extinction of auditory conditioned fear responses in a Pavlovian model.
    Liu JL; Li M; Dang XR; Wang ZH; Rao ZR; Wu SX; Li YQ; Wang W
    PLoS One; 2009 Oct; 4(10):e7548. PubMed ID: 19855841
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acquisition and expression of fat conditioned flavor preferences following dopamine D1, opioid and NMDA receptor antagonism in C57BL/6 mice.
    Iskhakova J; Mustac T; Yuabov A; Macanian J; Israel E; Dohnalova P; Iskhakov B; Lulu EB; Aminov S; Fazylov D; Bodnar RJ
    Nutr Neurosci; 2022 Jan; 25(1):137-145. PubMed ID: 32050863
    [No Abstract]   [Full Text] [Related]  

  • 59. Distribution of nociceptin and Ro64-6198 activated [35S]-GTPgammaS binding in the rat brain.
    Gehlert DR; Gackenheimer SL; Shaw JL
    Neuropeptides; 2006 Apr; 40(2):95-105. PubMed ID: 16403422
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of NMDA receptor in nociceptive effects elicited by intrathecal [Tyr6] gamma2-MSH(6-12), and the interaction with nociceptin/orphanin FQ in pain modulation in mice.
    Chang M; Li W; Peng YL; Gao YH; Yao J; Han RW; Wang R
    Brain Res; 2009 May; 1271():36-48. PubMed ID: 19332041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.